Your browser doesn't support javascript.
loading
A national multicenter phase 2 study of prostate-specific antigen (PSA) pox virus vaccine with sequential androgen ablation therapy in patients with PSA progression: ECOG 9802.
DiPaola, Robert S; Chen, Yu-Hui; Bubley, Glenn J; Stein, Mark N; Hahn, Noah M; Carducci, Michael A; Lattime, Edmund C; Gulley, James L; Arlen, Philip M; Butterfield, Lisa H; Wilding, George.
Affiliation
  • DiPaola RS; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. Electronic address: Robert.DiPaola@rutgers.edu.
  • Chen YH; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Bubley GJ; Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Stein MN; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Hahn NM; Indiana University Simon Cancer Center, Indianapolis, IN, USA.
  • Carducci MA; Johns Hopkins University, Baltimore, MD, USA.
  • Lattime EC; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Gulley JL; National Cancer Institute, Bethesda, MD, USA.
  • Arlen PM; National Cancer Institute, Bethesda, MD, USA.
  • Butterfield LH; University of Pittsburgh, Pittsburgh, PA, USA.
  • Wilding G; UW Carbone Cancer Center, University of Wisconsin, Madison, WI, USA.
Eur Urol ; 68(3): 365-71, 2015 Sep.
Article in En | MEDLINE | ID: mdl-25533418

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Kallikreins / Prostate-Specific Antigen / Cancer Vaccines / Androgen Antagonists Type of study: Clinical_trials Limits: Aged / Humans / Male / Middle aged Language: En Journal: Eur Urol Year: 2015 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Kallikreins / Prostate-Specific Antigen / Cancer Vaccines / Androgen Antagonists Type of study: Clinical_trials Limits: Aged / Humans / Male / Middle aged Language: En Journal: Eur Urol Year: 2015 Document type: Article Country of publication: